NDC properties for NDC 9 54436-275
NDC item 54436027501
NDC 9 | 54436-275 |
---|---|
NDC 10 | 54436-275-01 |
NDC Item | 54436027501 |
packaging | 1 SYRINGE in 1 CARTON (54436-275-01) / .5 mL in 1 SYRINGE (54436-275-03) |
DCSA | CIII |
FDA SPL set id | 860412 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |
NDC item 54436027502
NDC 9 | 54436-275 |
---|---|
NDC 10 | 54436-275-02 |
NDC Item | 54436027502 |
packaging | 0.5 mL in 1 SYRINGE |
DCSA | CIII |
FDA SPL set id | 860412 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |
NDC item 54436027503
NDC 9 | 54436-275 |
---|---|
NDC 10 | 54436-275-03 |
NDC Item | 54436027503 |
packaging | 0.5 mL in 1 SYRINGE |
DCSA | CIII |
FDA SPL set id | 860412 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |
NDC item 54436027504
NDC 9 | 54436-275 |
---|---|
NDC 10 | 54436-275-04 |
NDC Item | 54436027504 |
packaging | 4 SYRINGE in 1 CARTON (54436-275-04) / .5 mL in 1 SYRINGE (54436-275-02) |
DCSA | CIII |
FDA SPL set id | 860412 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |
NDC item 54436027505
NDC 9 | 54436-275 |
---|---|
NDC 10 | 54436-275-05 |
NDC Item | 54436027505 |
packaging | 1 SYRINGE in 1 CARTON (54436-275-05) / .5 mL in 1 SYRINGE (54436-275-02) |
DCSA | CIII |
FDA SPL set id | 860412 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |